Roska unit centers around healthcare

Share this article:
Roska Direct Advertising has restructured into three distinct units, including a rebranded healthcare advertising arm.

Roska Direct Advertising will focus on the consumer and business-to-business markets, while the Roska Healthcare Advertising unit will be specific to healthcare advertising, and Roska Digital Advertising will focus on digital marketing.

Roska veteran Jay Bolling has been selected to lead Roska Healthcare Advertising as its president. Bolling recently told MM&M that the new unit would undergo a “subtle” introduction to the industry under its new brand identity. The group's results, however, will be anything but subdued, he explained.

“What we are trying to do with Roska Healthcare Advertising is focus on a message that will be very similar to the overall message of Roska,” he said. 

In the past, the Roska healthcare unit has worked with clients including Pfizer, AstraZeneca, GlaxoSmithKline and Bristol-Myers Squibb.

Share this article:
close

Next Article in News

Email Newsletters

More in News

Sales of Biogen MS pill pick up overseas

Sales of Biogen MS pill pick up overseas

Biogen Idec is seeing strong sales for blockbuster MS drug Tecfidera, especially overseas where it's beginning to catch fire this summer.

GSK second-quarter sales disappoint

GSK second-quarter sales disappoint

Executives urge analysts to focus on the company's long-term potential.

House bill would speed approval once EU OKs same product

House bill would speed approval once EU OKs ...

The Speeding Access to Already Approved Pharmaceuticals Act of 2014 would require FDA to expedite the review of pharmaceuticals that are already approved by the European Union